Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic GMP/KATP …

E Alizamani, B Ghorbanzadeh… - International Journal …, 2021 - Taylor & Francis
Objective The leukotrienes are inflammatory mediators. In the present study, the analgesic
role of local montelukast, a cysteinyl leukotriene receptor antagonist, and the possible …

[PDF][PDF] Evaluation of analgesic, anti-inflammatory, and antipyretic activity of leukotriene receptor antagonist-montelukast: An experimental study

AM Kolhe, A Kale - National Journal of Physiology, Pharmacy and …, 2017 - njppp.com
Background: Various inflammatory mediators are involved in initiating and sustaining
pain/inflammation cascade. Recently, leukotrienes (LTs) have been shown to be important …

Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of montelukast in the animal models of pain

B Ghorbanzadeh, MT Mansouri, H Sahraei… - European Journal of …, 2016 - Elsevier
This study aimed to investigate the involvement of opioid receptors in the systemic and
peripheral antinociceptive activities of montelukast in different animal models of pain. Rats …

Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats

VP Singh, CS Patil, SK Kulkarni - Pharmacology Biochemistry and Behavior, 2005 - Elsevier
Pain is commonly associated with inflammation. Several mediators including prostaglandins
have been implicated in pain and inflammation. However, the recent reports indicated the …

Role of cysteinyl leukotrienes in nociceptive and inflammatory conditions in experimental animals

NK Jain, SK Kulkarni, A Singh - European journal of pharmacology, 2001 - Elsevier
The leukotrienes are potent inflammatory mediators, which may have a role in inflammatory
diseases such as allergic rhinitis, inflammatory bowl disease and asthma. Zafirlukast, a …

Leukotrienes in nociceptive pathway and neuropathic/inflammatory pain

K Noguchi, M Okubo - Biological and Pharmaceutical Bulletin, 2011 - jstage.jst.go.jp
The purpose of this review is to summarize the recent studies examining the expression of
leukotrienes (LTs) and their receptors in nociceptive pathways, and their crucial roles in …

Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction …

C Zhou, X Shi, H Huang, Y Zhu, Y Wu - Anesthesia & Analgesia, 2014 - journals.lww.com
BACKGROUND: Cysteinyl leukotrienes and their receptors have been shown to be involved
in the generation of neuropathic pain. We performed this study to determine the antagonistic …

Expression of leukotriene receptors in the rat dorsal root ganglion and the effects on pain behaviors

M Okubo, H Yamanaka, K Kobayashi… - Molecular …, 2010 - journals.sagepub.com
Background: Leukotrienes (LTs) belong to the large family of lipid mediators implicated in
various inflammatory conditions such as asthma and rheumatoid arthritis. Four distinct types …

Ameliorative potential of montelukast on ischemia–reperfusion injury induced vasculitic neuropathic pain in rat

A Muthuraman, M Ramesh, S Sood - Life sciences, 2012 - Elsevier
AIMS: Ischemia-reperfusion (I/R) event in vascular and nervous system has been
documented to rising ischemic and vasculitic neuropathic pain, clinically resembles the …

[HTML][HTML] Involvement of the L-arginine/nitric oxide/cyclic GMP/KATP channel pathway and PPARγ receptors in the peripheral antinociceptive effect of carbamazepine

B Ghorbanzadeh, V Kheirandish… - Drug Research, 2019 - thieme-connect.com
Carbamazepine has been shown to exert analgesic effects in clinical and experimental pain
situation. This study was conducted to evaluate its potential peripheral antinociceptive …